3/A

MAIN DOCUMENT DESCRIPTION

Company: ABVC BIOPHARMA, INC.
Filed: September 22, 2008
Period of Report: May 21, 2008
Accession Number: 0001209191-08-053008

View Document ↗ View on SEC.gov ↗